Distribution of granulocyte-monocyte colony-stimulating factor and its receptor α-subunit in the adult human brain with specific reference to Alzheimer's disease
- PMID: 22430742
- DOI: 10.1007/s00702-012-0794-y
Distribution of granulocyte-monocyte colony-stimulating factor and its receptor α-subunit in the adult human brain with specific reference to Alzheimer's disease
Abstract
Granulocyte-monocyte colony-stimulating factor (GM-CSF) is a member of the hematopoietic growth factor family, promoting proliferation and differentiation of hematopoietic progenitor cells of the myeloid lineage. In recent years, GM-CSF has also proved to be an important neurotrophic factor in the central nervous system (CNS) via binding to the GM-CSF receptor (GM-CSF R). Furthermore, studies on rodent CNS revealed a wide distribution of both the major binding α-subunit of the GM-CSF R (GM-CSF Rα) and its ligand. Since respective data on the expression pattern of these two molecules are still lacking, the present study has been designed to systematically analyze the protein expression of GM-CSF and GM-CSF Rα in the human brain, with particular emphasis on their regulation in Alzheimer's disease (AD). One major finding is that both GM-CSF and GM-CSF Rα were ubiquitously but not uniformly expressed in neurons throughout the CNS. Protein expression of GM-CSF and GM-CSF Rα was not restricted to neurons but also detectable in astrocytes, ependymal cells and choroid plexus cells. Interestingly, distribution and intensity of immunohistochemical staining for GM-CSF did not differ among AD brains and age-matched controls. Concerning GM-CSF Rα, a marked reduction of protein expression was predominantly detected in the hippocampus although a slight reduction was also found in various cortical regions, thalamic nuclei and some brainstem nuclei. Since the hippocampus is one of the target regions of neurodegenerative changes in AD, reduction of GM-CSF Rα, with consecutive downregulation of GM-CSF signaling, may contribute to in the progressive course of neurodegeneration in AD.
Similar articles
-
Distribution of the hematopoietic growth factor G-CSF and its receptor in the adult human brain with specific reference to Alzheimer's disease.J Anat. 2014 Apr;224(4):377-91. doi: 10.1111/joa.12154. Epub 2014 Jan 5. J Anat. 2014. PMID: 24387791 Free PMC article.
-
A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).J Cereb Blood Flow Metab. 2008 Jan;28(1):29-43. doi: 10.1038/sj.jcbfm.9600496. Epub 2007 Apr 25. J Cereb Blood Flow Metab. 2008. PMID: 17457367
-
Human GM-CSF interaction with the alpha-chain of its receptor studied using surface plasmon resonance.Biosens Bioelectron. 1999 Jun 30;14(6):555-67. doi: 10.1016/s0956-5663(99)00034-2. Biosens Bioelectron. 1999. PMID: 11459101
-
Role of GM-CSF in lung balance and disease.Front Immunol. 2023 Apr 4;14:1158859. doi: 10.3389/fimmu.2023.1158859. eCollection 2023. Front Immunol. 2023. PMID: 37081870 Free PMC article. Review.
-
Colony Stimulating Factor-1 Receptor: An emerging target for neuroinflammation PET imaging and AD therapy.Bioorg Med Chem. 2024 Feb 15;100:117628. doi: 10.1016/j.bmc.2024.117628. Epub 2024 Feb 1. Bioorg Med Chem. 2024. PMID: 38330850 Review.
Cited by
-
Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy.J Immunol. 2015 Jun 1;194(11):5085-93. doi: 10.4049/jimmunol.1403243. Epub 2015 Apr 27. J Immunol. 2015. PMID: 25917097 Free PMC article.
-
Innate immunity in Alzheimer's disease: a complex affair.CNS Neurol Disord Drug Targets. 2013 Aug;12(5):593-607. doi: 10.2174/1871527311312050008. CNS Neurol Disord Drug Targets. 2013. PMID: 23574177 Free PMC article. Review.
-
Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.Pharmacol Ther. 2022 Jun;234:108119. doi: 10.1016/j.pharmthera.2022.108119. Epub 2022 Jan 30. Pharmacol Ther. 2022. PMID: 35108575 Free PMC article. Review.
-
Bridge between neuroimmunity and traumatic brain injury.Curr Pharm Des. 2014;20(26):4284-98. Curr Pharm Des. 2014. PMID: 24025052 Free PMC article. Review.
-
STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosis.Mol Cancer Res. 2014 Sep;12(9):1267-82. doi: 10.1158/1541-7786.MCR-13-0652-T. Epub 2014 May 16. Mol Cancer Res. 2014. PMID: 24836891 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical